Clinical Trials Browser

BRCA1 Mutation × decitabine and cedazuridine drug combination × 30 days × Clear all

NCT06177171 2026-05-27

Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

Phase 1 Recruiting

BRCA1 Mutation